Biocryst Pharmaceuticals
Biocryst Pharmaceuticals's email is info@biocryst.com
and
Biocryst Pharmaceuticals's phone number is 9198591314
.
BioCryst Pharmaceuticals discovers novel, oral, small-molecule medicines that treat rare diseases in which significant unmet medical needs exist and an enzyme plays a key role in the biological pathway of the disease. Oral, once-daily ORLADEYO™ (berotralstat) is approved in the United States for the prevention of HAE attacks in adult and pediatric patients 12 years and older, and under regulatory review for approval in Japan and the European Union. BioCryst has several ongoing development programs including BCX9930, an oral Factor D inhibitor for the treatment of complem...
read more
BioCryst Pharmaceuticals discovers novel, oral, small-molecule medicines that treat rare diseases in which significant unmet medical needs exist and an enzyme plays a key role in the biological pathway of the disease. Oral, once-daily ORLADEYO™ (berotralstat) is approved in the United States for the prevention of HAE attacks in adult and pediatric patients 12 years and older, and under regulatory review for approval in Japan and the European Union. BioCryst has several ongoing development programs including BCX9930, an oral Factor D inhibitor for the treatment of complement-mediated diseases, galidesivir, a potential treatment for COVID-19, Marburg virus disease and Yellow Fever, and BCX9250, an ALK-2 inhibitor for the treatment of fibrodysplasia ossificans progressiva. RAPIVAB® (peramivir injection), a viral neuraminidase inhibitor for the treatment of influenza, is BioCryst’s first approved product and has received regulatory approval in the U.S., Canada, Australia, Japan, Taiwan, Korea and the European Union. Post-marketing commitments for RAPIVAB are ongoing.
show less
Website | biocryst.com | |
Industry | Biotechnology | |
Location | Durham, North Carolina, United States | |
Employees | 231 | |
Founded | 1986 |
HQ | 2190 Parkway Lake Drive | |
Phone | 919-859-1314 | |
info@biocryst.com | ||
Funding | 1,305,599,999 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | biocryst.com | |
Industry | Biotechnology | |
Location | Durham, North Carolina, United States | |
Employees | 231 | |
Founded | 1986 | |
linkedin.com/company/biocryst-pharmaceuticals | ||
HQ | 2190 Parkway Lake Drive | |
Phone | 919-859-1314 | |
info@biocryst.com | ||
Funding | 1,305,599,999 USD |
Email Patterns for Biocryst Pharmaceuticals
Top Competitors for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals Questions
Where are Biocryst Pharmaceuticals's headquarters?
Biocryst Pharmaceuticals's headquarters are in 2190 Parkway Lake Drive
What is Biocryst Pharmaceuticals's phone number?
Biocryst Pharmaceuticals's phone number is 9198591314
What is Biocryst Pharmaceuticals's official website?
Biocryst Pharmaceuticals's website is biocryst.com
How many employees are working in Biocryst Pharmaceuticals right now?
Biocryst Pharmaceuticals has
231 employees.
View the Email and Phone Numbers for all 231 working at Biocryst Pharmaceuticals.
What is Biocryst Pharmaceuticals's industry?
Biocryst Pharmaceuticals's industry is
Biotechnology
Who are Biocryst Pharmaceuticals's top competitors?
Biocryst Pharmaceuticals's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Biocryst Pharmaceuticals's email address?
Biocryst Pharmaceuticals's email address is info@biocryst.com
What are Biocryst Pharmaceuticals's categories?
Biocryst Pharmaceuticals's categories are Biotechnology, Clinical Trials, Therapeutics
What is Biocryst Pharmaceuticals's location?
Biocryst Pharmaceuticals's location is
Durham, North Carolina, United States
When was Biocryst Pharmaceuticals's founded?
Biocryst Pharmaceuticals's founding year is 1986
What is Biocryst Pharmaceuticals's funding?
Biocryst Pharmaceuticals's funding is 1,305,599,999 USD
What is Biocryst Pharmaceuticals's current status?
Biocryst Pharmaceuticals's current status is ipo
Top Biocryst Pharmaceuticals Employees
Global Medical Director, New Product Launch
jessica.best@upsher-smith.com
+1763-315-2659
Assistant Study Manager
joannparsi@gmail.com
+1919-285-1786
Senior Clinical Pharmacologist
apapinska@usc.edu
+1213-740-1492
Data Coordinator
charitylrussell@yahoo.com
+1205-422-3080
Manager, Global Regulatory Operations
dstaton21@gmail.com
+1919-886-4587
West Region Business Director
lizjo22@gmail.com
+1919-381-7314
Quality Assurance Manager
vtate@southernresearch.org
+1919-859-1302